Point72 Asia (Singapore) Pte. Ltd. Ideaya Biosciences, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 4,561 shares of IDYA stock, worth $146,590. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,561
Previous 476
858.19%
Holding current value
$146,590
Previous $10 Million
1141.43%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IDYA
# of Institutions
239Shares Held
82.1MCall Options Held
509KPut Options Held
103K-
Black Rock Inc. New York, NY6.81MShares$219 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.55MShares$211 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.43MShares$207 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.92MShares$158 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.63MShares$149 Million0.24% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.54B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...